BIOLIFE SOLUTIONS INC Quarterly Costs and Expenses in USD from Q1 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Biolife Solutions Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q2 2025.
  • Biolife Solutions Inc Costs and Expenses for the quarter ending June 30, 2025 was $42.1M, a 100% increase year-over-year.
  • Biolife Solutions Inc Costs and Expenses for the twelve months ending June 30, 2025 was $114M, a 124% increase year-over-year.
  • Biolife Solutions Inc annual Costs and Expenses for 2024 was $89.4M, a 9.98% decline from 2023.
  • Biolife Solutions Inc annual Costs and Expenses for 2023 was $99.3M, a 20.9% increase from 2022.
  • Biolife Solutions Inc annual Costs and Expenses for 2022 was $82.2M, a 46.8% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $114M $42.1M +$21M +100% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $92.8M $25.2M +$3.43M +15.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $89.4M $14.5M +$45.4M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 $44M $32.1M -$6.92M -17.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $50.9M $21M -$18.8M -47.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $69.7M $21.7M -$29.6M -57.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $99.3M -$30.9M +$101M +76.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 -$1.39M $39M -$13.4M -25.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $12.1M $39.9M -$77.2M -66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $89.3M $51.3M +$7.12M +16.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $82.2M -$132M -$187M -336% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-03
Q3 2022 $270M $52.5M +$7.53M +16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $262M $117M +$81.3M +227% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $181M $44.2M +$26.4M +148% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $154M $55.8M +$35.6M +177% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $119M $45M +$32.4M +259% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $86.2M $35.8M +$25.9M +262% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $60.4M $17.8M +$6.04M +51.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $54.3M $20.1M +$11.1M +122% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $43.3M $12.5M +$5.15M +69.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $38.1M $9.88M +$3.92M +65.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $34.2M $11.8M +$6.59M +127% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $27.6M $9.06M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $7.38M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.95M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $5.2M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.